|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Anesthesiology and Critical Care Medicine (Dr. Shander), Englewood Hospital and Medical Center, Englewood, NJ; and Haemonetics Corporation (Dr. Popovsky), Braintree, MA.
Correspondence to: Aryeh Shander, MD, FCCP, Chief, Department of Anesthesiology and Critical Care Medicine, Medical Director, New Jersey Institute for the Advancement of Bloodless Medicine and Surgery, Englewood Hospital and Medical Center, 350 Engle St, Englewood, NJ 07631; e-mail: aryeh.shander{at}ehmc.com
Although the blood supply has become safer with regard to transmission of infectious agents, attention should continue to focus on understanding and eliminating the other serious risks associated with transfusion. Transfusion-related acute lung injury (TRALI) is one such risk, only recently becoming recognized as an important and potentially preventable clinical syndrome. Strategies for prevention of TRALI, however, must rely on knowledge regarding its etiology and diagnosis, and significant gaps in our understanding of the syndrome currently exist. This review summarizes what is known and unknown about the incidence, severity, etiology, diagnosis, and prevention of TRALI and the potential consequences of these knowledge gaps.
Key Words: diagnosis etiology transfusion-related acute lung injury
This article has been cited by other articles:
![]() |
M. Zambon and J.-L. Vincent Mortality Rates for Patients With Acute Lung Injury/ARDS Have Decreased Over Time Chest, May 1, 2008; 133(5): 1120 - 1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Netzer, C. V. Shah, T. J. Iwashyna, P. N. Lanken, B. Finkel, B. Fuchs, W. Guo, and J. D. Christie Association of RBC Transfusion With Mortality in Patients With Acute Lung Injury Chest, October 1, 2007; 132(4): 1116 - 1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Kahn, L. Goitein, D. R. Ouellette, and R. S. Irwin Pharmaceutical Industry Sponsorship of Journal Supplements Chest, May 1, 2006; 129(5): 1387 - 1388. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |